Research Focus
The major goal of the Tumour Immunology Laboratory is to obtain a deeper understanding of the mechanisms by which an immune response to tumours may be generated, augmented and applied to the inhibition of tumour growth. The members of this laboratory share the expectation that such insight will be applicable to the treatment and/or prevention of cancer.
Gallery
Research Projects
Current Research Projects
Targeting ubiquitously expressed EBV cancer-associated antigen EBNA1 for immunotherapy.
Developing a prophylactic vaccine for human cytomegalovirus.
Design of recombinant therapeutic vaccines to EBV-associated nasopharyngeal carcinoma and Hodgkin’s lymphoma.
Funding
- National Health and Medical Research Council
- Cancer Council Queensland
- National Institutes of Health (US)
- Leukaemia Foundation
- Newro Foundation
Further Information
External Collaborations
- Prof. Alejandro Lopez (Griffith University)